Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd.

Press Release – New York, NY – December 30, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV). The offering included 4,144,068 American Depositary Shares (“ADSs”) sold to the public at $2.36 per ADS.  The gross proceeds of the offering to the company were approximately $9.8 million.

The offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333-2401889) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on August 10, 2020.  The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio and Avital Perlman, counsel Jennifer Trowbridge, associate Zachary Weiss and senior paralegal Raquel Vasquez.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

SRFC is a full-service law firm with nationally recognized corporate, securities, and litigation practices that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation and regulatory department specializes in defending broker-dealers, registered persons, public and private corporations, and individuals in investigations and enforcement proceedings before the SEC, FINRA, and other regulatory bodies, as well as litigations and arbitrations across all forums in the securities industry, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel LLP Represents Safe & Green Holdings Corp. in a $8.0 Million Private Placement - April 15, 2025
• Sichenzia Ross Ference Carmel LLP Represents FatPipe, Inc. in Closing of $4 Million Initial Public Offering - April 10, 2025
• Sichenzia Ross Ference Carmel Names Matilde Tysz as Chief Strategy Officer - April 9, 2025